Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13: From Immunization to Lead Optimization

Author:

Gevenois Philippe J.-L. Y.ORCID,De Pauw PieterORCID,Schoonooghe Steve,Delporte CédricORCID,Sebti Thami,Amighi Karim,Muyldermans SergeORCID,Wauthoz NathalieORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Single-Domain Antibodies—Novel Tools to Study and Treat Allergies;International Journal of Molecular Sciences;2024-07-11

2. Polyvalency: an emerging trend in the development of clinical antibodies;Drug Discovery Today;2024-01

3. Improvement of the sensitivity of lateral flow systems for detecting mycotoxins: Up‐to‐date strategies and future perspectives;Comprehensive Reviews in Food Science and Food Safety;2023-12-13

4. Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review);International Journal of Molecular Medicine;2023-12-06

5. Abstracts from The International Society for Aerosols in Medicine;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3